Ellen Carl

Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation

Sphingolipids and their metabolism in physiology and disease

Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice

Susceptibility phase imaging with comparison to R2* mapping of iron-rich deep grey matter

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

Advanced MRI and staging of multiple sclerosis lesions

Vascular aspects of multiple sclerosis

MRI assessment of iron deposition in multiple sclerosis

Immunopathology of multiple sclerosis

Development, maintenance and disruption of the blood-brain barrier

Cognitive impairment and cardiovascular disease: So near, so far

The role of iron in brain ageing and neurodegenerative disorders

Tripping on nothing: placebo psychedelics and contextual factors

Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain

Amyotrophic lateral sclerosis: A neurovascular disease

The Pathobiology of Vascular Dementia

Brain angiotensin receptor subtypes in the control of physiological and behavioral responses

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Early CNS neurodegeneration in radiologically isolated syndrome

Hematopoietic mobilization

Multiple Sclerosis

Determinants of brain iron in multiple sclerosis

Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology

International Union of Pharmacology. XXIII. The Angiotensin II Receptors

Impairment of paravascular clearance pathways in the aging brain

Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions

American Trip

Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report

Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis

Phase White Matter Signal Abnormalities in Patients with Clinically Isolated Syndrome and Other Neurologic Disorders

Genetic Expression of Amyloid and Glial-specific Protein in the Alzheimer Brain

Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis

Iron deposition in multiple sclerosis lesions measured by susceptibility‐weighted imaging filtered phase: A case control study

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis

Prospective randomized trial of venous angioplasty in MS (PREMiSe)

Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis

The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics.

Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS

Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.